Phacilitate Leaders Forum

29TH - 30TH SEPTEMBER 2020

ETC BISHOPSGATE LONDON

Speakers

Loading
Eleuterio Lombardo, PhD.

Eleuterio Lombardo, PhD.

Director of Cell Therapy Characterization & Development, Cell Therapies, Takeda Madrid Cell Therapy Technology Center

Eleuterio holds a Ph.D in Biochemistry and Molecular Biology from the Universidad Autónoma de Madrid (Spain) and has more than 25 years of research experience in the fields of virology, toll-like receptors, innate immunity, inflammation and stem cell biology. He developed his academic scientific career in some of the most important research institutions in Spain, and The United States (The Salk Institute and The Scripps Research Institute). He joined TiGenix (now part of Takeda) 12 years ago where, as Scientific Director, he has been responsible of generating a robust non-clinical package that supported the EU commercialization approval of Alofisel (allogeneic adipose mesenchymal stem cells (ASCs)) for the treatment of complex perianal fistulas in Crohn´s patients, and paved the clinical development of ASCs in other indications such as sepsis and rheumatoid arthritis. Eleuterio is the Project Coordinator of SEPCELL, the H2020 EU funded Consortium investigating the use of allogeneic ASCs in the treatment of sepsis (SEPCELL trial).

Testimonials
  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Jean-Philippe Combal
    GenSight Biologics
  • The conference consistently proves to be a great forum for networking with industry leaders in the development of cellular and gene therapies as well as vendors for important technologies and services.
    Michael Covington
    Juno Therapeutics, Inc
  • It was a very interesting event as all participants, including speakers were ready to exchange, even on the most challenging subjects such as reimbursement, GMP guidance
    Bertrand Alexandre
    Celyad
  • Phacilitate EU delivered it's promise and more, the topics discussed were highly relevant, with very good and professional speakers and panelists. You will see me next year in Berlin.
    Dr Ohad Karnieli
    Karnieli Ltd